InvestorsHub Logo
Followers 827
Posts 119469
Boards Moderated 15
Alias Born 09/05/2002

Re: None

Monday, 12/15/2014 1:09:04 PM

Monday, December 15, 2014 1:09:04 PM

Post# of 20689
MNTA could be affected today by a BioCentury article that mistakenly says FDA can’t approve Copaxone ANDA until the patent case is resolved.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”